Literature DB >> 11486197

Intermediate outcome after Mustard and Senning procedures: A study by the Congenital Heart Surgeons Society.

Winfield J. Wells1, Eugene Blackstone.   

Abstract

Although atrial switch is rarely performed today except as part of a "double switch" operation, there continues to be interest in the long-term outcome of the procedure because of the many Mustard and Senning survivors who are in follow-up. In contrast to most other reported series on atrial switch, this study by the Congenital Heart Surgeons Society (CHSS) is a prospective multiinstitutional study of patients encountered in a relatively short time frame during the late 1980s. Between 1985 to 1989, 20 centers with surgeons belonging to the CHSS prospectively registered patients <15 days of age presenting with simple or complex transposition of the great arteries (TGA). The patients were assigned to protocol groups based on intent to treat (arterial switch, Mustard, or Senning). Data were abstracted in the Data and Analysis Center, which in most cases, conducted the annual follow-up. Among the 281 patients who had an atrial switch, there were 108 Mustard and 173 Senning procedures. For the combined atrial switch population, the survival at 1 month, 5 years and 10 years was 90%, 85%, and 84%, respectively. Results for the Mustard were better than for the Senning with survival at 1 month, 5 years, and 10 years being 96% versus 86%, 95% versus 80%, 93% versus 78%; (P <.001) for Mustard versus Senning. While the major mortality risk occurred in the first postoperative month for both groups, thereafter, the late rate of death from 1 to 10 years after operation was 0.78%/year Senning versus 0.23%/year Mustard (P <.05). TGA/ventricular septal defect (VSD), lower weight, younger age, cardiac positional anomalies, and procedures on the left ventricle (LV) outflow all correlated significantly with poor outcome. There were 19 reoperations including 2 for right ventricle (RV) failure, 12 for pathway obstruction, and 5 for baffle leak with a 36% overall mortality. Freedom from any pathway obstruction at 10 years was 95%. A permanent pacemaker was required in 21 patients with the significant risk factors including TGA/VSD and a Senning, and previous atrial septectomy. Freedom from a pacemaker insertion at 10 years was 91%. For both Mustard and Senning, 60% of patients were in New York Heart Association (NYHA) functional Class I with the remaining in Class II. This study of atrial switch outcomes by the CHSS suggests that the subgroup undergoing a Mustard procedure had better early and late survival than those undergoing a Senning operation. The overall incidence of baffle pathway obstruction was low though reoperation for this complication carried high risk. Serious arrhythmia requiring medication and the need for a permanent pacemaker were both relatively uncommon. The incidence of severe right heart failure was very low, although only 60% of patients are unrestricted in their activity. Copyright 2000 by W.B. Saunders Company

Entities:  

Year:  2000        PMID: 11486197     DOI: 10.1053/tc.2000.6043

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu        ISSN: 1092-9126


  8 in total

1.  Successful use of covered stent to treat superior systemic baffle obstruction and leak after atrial switch procedure.

Authors:  Andreea Dragulescu; Noumou Sidibe; Francoise Aubert; Alain Fraisse
Journal:  Pediatr Cardiol       Date:  2007-12-19       Impact factor: 1.655

Review 2.  Monitoring the patient with transposition of the great arteries: arterial switch versus atrial switch.

Authors:  Susan Lucy Roche; Candice Kristine Silversides; Erwin Notker Oechslin
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

3.  Superior vena cava stenting and transvenous pacemaker implantation (stent and pace) after the Mustard operation.

Authors:  Mathias Emmel; Narayanswami Sreeram; Konrad Brockmeier; Gerardus Bennink
Journal:  Clin Res Cardiol       Date:  2006-10-30       Impact factor: 5.460

4.  Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries.

Authors:  L Dos; L Teruel; I J Ferreira; J Rodriguez-Larrea; L Miro; J Girona; D C Albert; A Gonçalves; M Murtra; J Casaldaliga
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

5.  Mustard baffle obstruction and leak - How successful are percutaneous interventions in adults?

Authors:  Elisa A Bradley; Amanda Cai; Sharon L Cheatham; Joanne Chisolm; Tracey Sisk; Curt J Daniels; John P Cheatham
Journal:  Prog Pediatr Cardiol       Date:  2015-10-22

6.  Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium.

Authors:  P Moons; M Gewillig; T Sluysmans; H Verhaaren; P Viart; M Massin; B Suys; W Budts; A Pasquet; D De Wolf; A Vliers
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

7.  Linking the congenital heart surgery databases of the Society of Thoracic Surgeons and the Congenital Heart Surgeons' Society: part 1--rationale and methodology.

Authors:  Jeffrey P Jacobs; Sara K Pasquali; Erle Austin; J William Gaynor; Carl Backer; Jennifer C Hirsch-Romano; William G Williams; Christopher A Caldarone; Brian W McCrindle; Karen E Graham; Rachel S Dokholyan; Gregory J Shook; Jennifer Poteat; Maulik V Baxi; Tara Karamlou; Eugene H Blackstone; Constantine Mavroudis; John E Mayer; Richard A Jonas; Marshall L Jacobs
Journal:  World J Pediatr Congenit Heart Surg       Date:  2014-04

8.  Palliative Senning in the Treatment of Congenital Heart Disease with Severe Pulmonary Hypertension.

Authors:  Juliano Gomes da Penha; Leina Zorzanelli; Antonio Augusto Barbosa-Lopes; Edimar Atik; Leonardo Augusto Miana; Carla Tanamati; Luiz Fernando Caneo; Nana Miura; Vera Demarchi Aiello; Marcelo Biscegli Jatene
Journal:  Arq Bras Cardiol       Date:  2015-08-18       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.